Case Strategy
Why Early Case Review Saves Time and Money
A short pre-suit medical review is the highest-leverage dollar a plaintiff firm spends — and the cheapest insurance a defense firm carries.
The economics of medical litigation reward early clarity. By the time a case reaches formal discovery, the firm has typically absorbed intake costs, records subpoenas, initial motion practice, and the opportunity cost of every hour spent on a claim that could have been declined. A structured medical review at intake — often two to four hours of a physician's time — reframes the entire investment curve. Either the case is medically sound and the firm proceeds with a defensible theory, or the case is not, and the firm redirects those resources to matters with better merit.
On the plaintiff side, early review answers three questions that summary judgment eventually asks anyway: Was there a breach of the standard of care? Did that breach, more likely than not, cause the injury? Are the damages medically consistent with the alleged mechanism? A physician can answer these questions from the four corners of the records long before depositions begin. When the answers align, the case moves forward with confidence. When they don't, the firm avoids the far larger cost of pursuing a claim that a jury — or a Daubert motion — will reject.
On the defense side, early review sharpens the theory of the case before opposing experts anchor the narrative. It identifies the strongest medical defenses, flags the weakest documentation in the chart, and clarifies where settlement makes economic sense versus where the case is worth trying. Defense counsel who wait until expert disclosures to engage medical review often find themselves reactive rather than strategic.
The pattern is consistent across specialties: the firms that build a habit of early medical consultation carry a stronger docket, spend less on cases that don't warrant the spend, and preserve credibility with judges and opposing counsel by filing only what they can defend.